New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
11:12 EDTTEVATeva price target raised to $57 from $53 at BMO Capital
BMO Capital raised its price target for Teva shares to $57 after the Supreme Court agreed to hear the company's appeal in its case against Momenta (MNTA), Novartis (NVS) and Mylan (MYL). BMO thinks Copaxone generics will not meaningfully affect 2014 and keeps an Outperform rating on the stock.
News For TEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
06:28 EDTTEVAAllergan price target raised to $210 from $190 at Citigroup
Subscribe for More Information
October 14, 2014
11:23 EDTTEVABIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
11:19 EDTTEVATeva upgraded to Buy from Hold at Standpoint Research
October 9, 2014
16:11 EDTTEVAAlexza reports 32,278 Adasuve units shipped to Teva in Q3
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use